Immune checkpoint inhibitors (ICIs) have shown impressive efficacy in many different cancer types, but not in head and neck cancer: could nodal irradiation blunt the immune response?
Medscape Medical News
Could Nodal RT Explain Failure of ICIs in Head and Neck Cancer?
